The DEG-enriched pathways mainly included transcriptional misregulation, growth hormone synthesis, secretion and action, endocrine resistance, axon guidance, and Cushing syndrome. This evidence concerns the gene GH1 and Cushing syndrome due to macronodular adrenal hyperplasia.